Robin Huff

Robin Huff Email and Phone Number

Executive Vice President, Drugs and Biologics Team @ ELIQUENT Life Sciences
Raleigh, NC, US
Robin Huff's Location
Raleigh, North Carolina, United States, United States
Robin Huff's Contact Details

Robin Huff personal email

n/a

Robin Huff phone numbers

About Robin Huff

Senior regulatory/clinical development professional with extensive experience from both FDA and the pharmaceutical/biologics industry. Develops worldwide strategies for clinical programs that consider commercial implications and minimize timelines, while maintaining a high likelihood of regulatory approval. Has extensive knowledge of the drug development process that derives from her 7 years of reviewer and supervisor experience in two divisions of CDER, her 10 years of leading a regulatory strategy group for a company that had both early and late stage global development programs, 5 years at the world's largest CRO, her role within the Rare Disease Organization of a mid-size biopharmaceutical company and her current position in one of the world's largest pharmaceutical companies.

Robin Huff's Current Company Details
ELIQUENT Life Sciences

Eliquent Life Sciences

View
Executive Vice President, Drugs and Biologics Team
Raleigh, NC, US
Website:
eliquent.com
Employees:
369
Robin Huff Work Experience Details
  • Eliquent Life Sciences
    Executive Vice President, Drugs And Biologics Team
    Eliquent Life Sciences
    Raleigh, Nc, Us
  • Takeda
    Executive Director, Global Regulatory Affairs - Neuroscience
    Takeda May 2022 - Present
    Tokyo, Jp
    • Collaborate with cross-functional team members on Global Project Team to define a development program that maximizes the probability of regulatory and access success• Lead a global team to develop and implement regulatory submission strategy for late-stage small molecule asset• Influence development of earlier stage assets through oversight of direct reports
  • Ucb
    Global Regulatory Lead, Rare Disease Organization
    Ucb Jul 2020 - May 2022
    Brussels, Be
    • Led a global team of US, EU, Japan, China, and ROW regulatory representatives to develop and implement regulatory strategy for 4 – 6 indications for a monoclonal antibody• Indications included neurological and hematological disorders of an autoimmune origin• Led cross-functional team to identify effective means of presenting subgroup data that culminated in approval of a differentiated indication statement• Collaborated with functional group leads and submission project manager to facilitate a detailed submission plan in order to achieve simultaneous global submissions• Led Submission Advisory Forum meetings with senior leadership to keep them apprised of key risks and mitigations and to benefit from their guidance
  • Ucb
    Global Regulatory Lead, Neurology
    Ucb Jun 2017 - Jun 2020
    Brussels, Be
    • Led a team of regional regulatory leads (US, EU, Japan and China) to develop global regulatory strategy for company’s lead development asset in neurology• Led meetings with FDA, EMA, PMDA and the Chinese CDE, achieving acceptance of an integrated development plan across the regions that maximized efficiencies for the clinical program• Made key contributions to study designs and accompanying rationale for submissions to regulatory authorities and HTAs to facilitate acceptance of company positions - Advocated proposing a continuous endpoint rather than the traditionally accepted dichotomous endpoint for an actively controlled trial in order to achieve feasible sample size; approach was successful• Led company’s first joint regulator/payer meeting (EMA/EUnetHTA Parallel Consultation)• Led due diligence activities that culminated in the purchase of the subject company and my leading of an EOP2 meeting with FDA within one week of deal closure
  • Quintiles
    Senior Director, Pediatric And Rare Diseases Centers Of Excellence
    Quintiles Nov 2012 - Jun 2017
    • Provided strategic drug development guidance to customers and internal teams, helping to shape clinical development programs that maximize value for both patients and drug manufacturers• Applied experience gained at FDA and in industry to the design of clinical programs, and negotiated with global regulatory authorities to gain acceptance of same• Maintained awareness of and influenced emerging clinical development policy through submission of comments on regulatory guidances and responses to published literature• Prepared and presented educational materials for external and internal audiences
  • Grifols Therapeutics
    Senior Director, Regulatory Coordination
    Grifols Therapeutics Jul 2011 - Nov 2012
    Sant Cugat Del Vallès, Barcelona, Es
    • Served as Head of the Regulatory Coordination department, charged with development of strategy to support clinical development projects and major manufacturing changes
  • Talecris Biotherapeutics
    Senior Director, Regulatory Affairs
    Talecris Biotherapeutics Apr 2007 - Jul 2011
    Talecris was acquired by Grifols in 2011 (see above).
  • Talecris Biotherapeutics
    Director, Regulatory Affairs
    Talecris Biotherapeutics Apr 2005 - Apr 2007
  • Bayer Biological Products
    Deputy Director, Regulatory Affairs
    Bayer Biological Products May 2003 - Mar 2005
    The assets of Bayer Biologicals were sold in 2005 and became owned by Talecris Biotherapeutics (see above).
  • Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products
    Supervisory Reviewer
    Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products Aug 1999 - May 2003
    Silver Spring, Md, Us
    • Led a team of reviewers in the evaluation of INDs and NDAs• Chaired FDA Committee for Advanced Scientific Education, 1999/2000
  • Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products
    Quality Assurance Program Detail, Part Time
    Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products Jul 2000 - Oct 2000
    Silver Spring, Md, Us
  • Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products
    Regulatory Reviewer
    Fda, Center For Drug Evaluation And Research, Division Of Pulmonary And Allergy Drug Products Jul 1996 - Aug 1999
    Silver Spring, Md, Us
  • National Institutes On Drug Abuse
    Pharmacology Research Associate (Prat)
    National Institutes On Drug Abuse Jul 1994 - Jul 1996

Robin Huff Skills

Clinical Development Regulatory Affairs Drug Development Clinical Trials Fda Biopharmaceuticals Medical Devices Biologics Ema Pharmaceuticals Regulatory Strategy Novel Product Development Life Cycle Management

Robin Huff Education Details

  • Duke University
    Duke University
    Pharmacology
  • Virginia Tech
    Virginia Tech
    Biochemistry

Frequently Asked Questions about Robin Huff

What company does Robin Huff work for?

Robin Huff works for Eliquent Life Sciences

What is Robin Huff's role at the current company?

Robin Huff's current role is Executive Vice President, Drugs and Biologics Team.

What is Robin Huff's email address?

Robin Huff's email address is ro****@****ucb.com

What is Robin Huff's direct phone number?

Robin Huff's direct phone number is +191389*****

What schools did Robin Huff attend?

Robin Huff attended Duke University, Virginia Tech.

What skills is Robin Huff known for?

Robin Huff has skills like Clinical Development, Regulatory Affairs, Drug Development, Clinical Trials, Fda, Biopharmaceuticals, Medical Devices, Biologics, Ema, Pharmaceuticals, Regulatory Strategy, Novel Product Development.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.